
Amkay Products Limited IPO
Amkay Products Ltd is a prominent company serving medical professionals, hospitals, and retailers across globe with high-quality & cost-effective in every product. The company draws its strength from skilled and trained staff to achieve the goal of customer satisfaction with every product. In our perspective, immediate response, providing products on time, and honoring committed delivery times are essential elements along with ensuring the quality of products.
At Amkay, we believe in going beyond the traditional ways of doing business. Our goal is to combine our products, resources, and operations with our values to benefit people not just in India but globally. Amkay Products IPO is a book-built issue of Rs 12.61 crores. The issue is entirely a fresh issue of 22.92 lakh shares. Amkay Products IPO price band is set at ₹52 to ₹55 per share. The minimum lot size for an application is 2000 Shares. Hem Securities Limited is the book running lead manager of the Amkay Products IPO, while Bigshare Services Pvt Ltd is the registrar for the issue. The market maker for Amkay Products IPO is Hem Finlease.

WHAT IS GMP?
GMP (Grey Market Premium) is the difference between the IPO price and the grey market price. It is the premium amount paid for the traded IPO shares. It plays an important role in IPOs as it reflects how the IPO would react on the listing day.
A grey market is a place where shares/stocks are traded before being listed officially on the stock exchange.
Amkay Products Limited IPO
GMP Date | IPO Price | GMP | Last Updated |
---|---|---|---|
- | - | - | - |
**The GMP prices displayed here are solely for informational purposes related to the grey market news. India IPO does not engage in or facilitate grey market trading, nor are these rates (sub2) indicative of any trading activity. We also do not recommend or endorse participation in the grey market.**
Amkay Products Limited IPO Details
Detail | Description |
---|---|
IPO Date | April 30, 2024 to May 3, 2024 |
Listing Date | - |
Face Value | ₹10 per share |
Price Band | ₹52 to ₹55 per share |
Lot Size | 2000 Shares |
Total Issue Size | 2,292,000 shares (aggregating up to ₹12.61 Cr) |
Fresh Issue | 2,292,000 shares (aggregating up to ₹12.61 Cr) |
Issue Type | Book Built Issue IPO |
Listing At | BSE SME |
Share holding pre issue | 6,363,640 |
Share holding post issue | 8,655,640 |
Market Maker portion | 120,000 shares Hem Finlease |
Amkay Products Limited IPO Timeline
Detail | Description |
---|---|
IPO Open Date | Tuesday, April 30, 2024 |
IPO Close Date | Friday, May 3, 2024 |
Basis of Allotment | Monday, May 6, 2024 |
Initiation of Refunds | Tuesday, May 7, 2024 |
Credit of Shares to Demat | Tuesday, May 7, 2024 |
Listing Date | Wednesday, May 8, 2024 |
Cut-off time for UPI mandate confirmation | 5 PM on May 3, 2024 |
Amkay Products Limited IPO Lot Size
Application | Lots | Shares | Amount |
---|---|---|---|
Retail (Min) | 1 | 2000 | ₹110,000 |
Retail (Max) | 1 | 2000 | ₹110,000 |
HNI (Min) | 2 | 4,000 | ₹220,000 |
Amkay Products Limited IPO Promoter Holding
Share Holding Pre Issue | Share Holding Post Issue |
---|---|
Shareholding Pre Issue | 99.89% |
Shareholding Post Issue | 73.44% |
Competitive Strength:
- -
Amkay Products Limited IPO Financial Information
Period Ended | Assets | Revenue | Profit After Tax | Net Worth | Total Borrowing | |||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
31 Dec 2023 | 1,887.52 | 2,385.56 | 215.34 | 986.96 | 476.22 | |||||||||||||||||||||||||||||||||||
31 Mar 2023 | 1,563.77 | 2,825.05 | 151.02 | 771.62 | 469.98 | |||||||||||||||||||||||||||||||||||
31 Mar 2022 | 1,580.64 | 3,679.45 | 146.71 | 620.60 | 433.59 | |||||||||||||||||||||||||||||||||||
31 Mar 2021 | 1,393.47 | 4,071.74 | 312.68 | 473.90 | 136.54 | |||||||||||||||||||||||||||||||||||
Amount in ₹ Crore |
Key Performance Indicator
KPI | Values |
---|---|
ROE | 24.49% |
ROCE | 21.54% |
Debt/Equity | 0.48 |
RoNW | 21.82% |
P/BV | 3.55 |
PAT Margin (%) | 9.47 |
Pre IPO | Post IPO | |
---|---|---|
EPS (Rs) | 2.37 | 3.32 |
P/E (x) | 23.18 | 16.58 |
Objectives of Amkay Products Limited IPO
The company intends to utilize the proceeds of the Issue to meet the following objectives:
- 1. Funding Capital Expenditure towards the installation of additional Machinery.
- 2. To meet working capital requirements.
- 3. General Corporate Purpose.
Amkay Products Limited IPO review
The company is in the medical device segment, which is not only overcrowded, but also on the verge of saturation point. It’s a highly competitive and fragmented segment post covid. Based on FY24 annualized earnings, the issue is fully priced discounting all near term positives. Well-informed/cash surplus investors may park moderate funds for the medium to long term rewards.
RHP:
DRHP:
Read more :
Frequently asked Questions (FAQs )
-
Why Amkay Products IPO?
The initial public offer (IPO) of Amkay Products Limited offers an early investment opportunity in Amkay Products Limited. A stock market investor can buy Amkay Products IPO shares by applying in IPO before Amkay Products Limited shares get listed at the stock exchanges. An investor could invest in Amkay Products IPO for short term listing gain or a long term.
-
Amkay Products IPO what should investors do?
Amkay Products IPO offers an opportunity to buy IPO shares before they get listed at the stock exchanges.
-
Is Amkay Products IPO good?
Our recommendation for Amkay Products IPO is to subscribe for long term.
-
When will Amkay Products IPO allotment status?
The Amkay Products IPO allotment status will be available on or around May 6, 2024. The allotted shares will be credited in demat account by May 7, 2024.